What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
AI has not replaced traditional diagnosis in healthcare. It can analyze images and signals, estimate risks, or suggest diagnoses from clinical text—but those are different tasks, and a tool’s standalone score does not show that using it helps a clinician or improves patient care. Current evidence points to a more useful question than “Can AI beat doctors?”: how well does a particular tool perform for a particular task, and what happens when clinicians use it?
What counts as AI diagnosis?
“AI diagnosis” describes several kinds of software, not one machine that examines a patient and reaches a complete diagnosis. Depending on its intended use, a system may analyze a medical image, process a signal, estimate a risk, or generate diagnostic suggestions from clinical text or a case description. These tools may work independently in a test or as one input in a clinician’s workflow.
Traditional diagnosis is also more than a single answer: clinicians draw on a patient’s history, examination, tests, and clinical judgment. A fair comparison therefore has to match the AI and clinician to the same diagnostic task and patient population, and clarify whether the tool is being assessed on its own or alongside a clinician.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →How accurate is AI compared with doctors?
A 2025 systematic review and meta-analysis in npj Digital Medicine examined 83 studies of generative-AI diagnostic tasks published from June 2018 through June 2024. Across those studies, reported overall diagnostic accuracy was 52.1%. The review found no statistically significant difference between generative AI and physicians overall (p=0.10), or between AI and non-expert physicians (p=0.93). Generative AI performed significantly worse than expert physicians (p=0.007). Read the review.
#1 Best Overall
The 52.1% figure is an aggregate across the review’s included studies, not the chance that an AI will correctly diagnose a particular person. Results can differ with the model, specialty, task, patient group, and test conditions. Also, “no statistically significant difference” does not prove that AI and physicians are equivalent; it means the review did not establish a statistically significant difference for those comparisons.
Image-analysis studies raise a related caution about how benchmark results translate into care. A 2020 BMJ systematic review assessed 81 non-randomized clinical trials of deep-learning medical imaging, covering evidence from 2010 through June 2019. Nine trials were prospective, six tested systems in real-world clinical settings, and 58 had high overall risk of bias. The review also reported that comparison groups were often small and access to data or code was frequently unavailable. These are findings about that review’s evidence base—not a characterization of every study published since. Read the review.
Does AI help clinicians make better diagnoses?
That is a different question from whether an AI model can answer diagnostic test questions accurately on its own. To assess assistance, a study needs to compare clinician performance with and without the tool, or evaluate an AI-assisted workflow in practice. A 2021 systematic review of 37 studies in JAMA Network Open found no robust evidence that using machine-learning decision-support systems improved clinicians’ diagnostic performance. The authors highlighted sparse evidence and the importance of studying human-computer interaction. Read the review.
When judging an “AI improves diagnosis” claim, check what the study actually compared:
- AI alone versus clinicians: tests standalone performance, not whether a clinician benefits from the tool.
- Clinicians with versus without AI: addresses whether assistance changes clinician performance.
- A deployed workflow: can show how the system functions in practice; patient-relevant outcomes matter if the study measures them.
A clinician-plus-AI result can depend on the workflow as well as the model: what information users see, when they see it, whether they can challenge or override a suggestion, and how a recommendation affects subsequent care. An accuracy score alone does not answer those questions.
How to assess a claim that an AI diagnostic tool is better
Use the same yardstick for the AI and its comparator. A credible comparison should make clear what condition or decision is being assessed, who the patients are, and whether the clinician comparator is a generalist or a specialist. It should also distinguish a retrospective benchmark from prospective testing or evaluation in real clinical settings.
Rank #4
- Check the reference standard: find out what the study treated as the correct diagnosis and how it was established.
- Look beyond accuracy: ask whether the reported measures fit the clinical task and what kinds of errors they reveal.
- Check external validation: determine whether the tool was evaluated beyond the data or setting used to develop it.
- Separate model performance from team performance: for an assisted workflow, look for evidence about clinician interaction, overrides, and downstream care when measured.
- Read the study design alongside the result: prospective and real-world evaluation, comparison-group size, and risk of bias affect how confidently findings apply elsewhere.
FDA’s transparency principles for machine-learning-enabled medical devices emphasize evaluating human-AI team performance and giving users clear, essential information. They offer useful questions for assessing a tool, but do not establish that any specific system is safe, effective, or right for an individual patient. Read FDA’s transparency principles.
What FDA oversight means in the United States
In the United States, FDA regulates medical devices, including some AI-enabled devices, based on factors such as intended use and technological characteristics. The agency’s device list reported more than 1,600 AI-enabled medical devices authorized for marketing as of September 2026. That changing count is not a tally of autonomous diagnostic systems and does not, by itself, demonstrate comparative clinical benefit. See FDA’s AI-enabled medical devices page.
Best Value
FDA’s clinical decision-support materials distinguish software functions that may be subject to device oversight from certain functions that are not devices under the relevant statutory criteria. For example, software that analyzes medical images or signals may fall within device oversight. One criterion discussed for certain non-device clinical decision-support functions is whether a healthcare professional can independently review the basis for a recommendation, rather than primarily relying on it for an individual patient’s diagnosis or treatment decision. The details depend on the function and context; this US framework should not be assumed to apply in other jurisdictions. Read FDA’s clinical decision-support guidance.
What the evidence supports—and what it does not
The evidence supports treating diagnostic AI as a set of task-specific tools to evaluate, not as a general substitute for clinicians. Generative AI’s pooled result in one review does not settle how a particular model will perform in a specialty or clinical workflow, and standalone accuracy cannot establish that AI assistance improves diagnosis or patient outcomes. For any specific claim, the task, comparator, study setting, validation, and role of the clinician are central to interpreting the result.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Recommended Free Tools
